FDA Approves GSK Hepatitis B Drug Hibsago
The FDA approved Hibsago, also known as bepirovirsen, for hepatitis B. GSK said the drug may help patients keep the virus under control after stopping treatment.
The US FDA said on Tuesday it had approved British drugmaker GSK's LSE:GSK hepatitis B drug Hibsago, offering patients with the liver infection a way to keep the virus under control after stopping treatment.The drug, chemically known as bepirovirsen, is the first FDA-approved antisense oligonucleot…